GYRE THERAPEUTICS, INC. Quarterly Return On Equity in % from Q3 2023 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Gyre Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2023 to Q3 2024.
  • Gyre Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -114 %, a 615% decline year-over-year.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -114 -97.7 -615% Jul 1, 2024 Sep 30, 2024
Q2 2024 -112 Apr 1, 2024 Jun 30, 2024
Q1 2024 -120 Jan 1, 2024 Mar 31, 2024
Q4 2023 -135 Oct 1, 2023 Dec 31, 2023
Q3 2023 -15.9 Jul 1, 2023 Sep 30, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.